|
|
||||||||
AJP - Renal Physiology, Vol 270, Issue 5 784-F789, Copyright © 1996 by American Physiological Society
ARTICLES |
Y. Wakabayashi and R. Kikawada
Department of Medicine, University of Kitasato Medical School, Sagamihara, Japan.
Because myoglobin is a potent inhibitor of nitric oxide (NO), we tested whether myoglobin infusion results in renal vasoconstriction and dysfunction, on which L-arginine, a source of NO, has a protective effect in sedated, nondehydrated, and nonacidotic rabbits. The infusion of myoglobin (375 mg/kg) resulted in a decrease in renal blood flow, an increase in renal vascular resistance, and a decrease in creatine clearance associated with a decrease in urinary excretory rate of nitrite/nitrate and guanosine 3',5'-cyclic monophosphate (cGMP). These values 1-2 h after the infusion were significantly different from baseline levels. Co-administration of L-arginine (150 mg/kg bolus followed by 150 mg.kg(-1).min(-1) reversed these changes significantly with attenuation of urinary excretory rate of nitrite/nitrate and cGMP. This study suggests that the myoglobin-induced renal vasoconstriction and dysfunction and protective effect of L-arginine on these outcomes could be mediated through the NO system.
This article has been cited by other articles:
![]() |
D. H. Warden, A. J. Croatt, Z. S. Katusic, and K. A. Nath Characterization of acute reversible systemic hypertension in a model of heme protein-induced renal injury Am J Physiol Renal Physiol, July 1, 1999; 277(1): F58 - F65. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-T. Dijkhorst-Oei, T. J. Rabelink, P. Boer, and H. A. Koomans Nifedipine Attenuates Systemic and Renal Vasoconstriction During Nitric Oxide Inhibition in Humans Hypertension, May 1, 1997; 29(5): 1192 - 1198. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |